Onconetix annual r&d spending
2021
2022
2023
2024
2025
Onconetix R&D Spending Growth & History (ONCO)
Onconetix's r&d spending was $66,133 for fiscal 2025.
View full Onconetix company overviewOnconetix annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $66,133 | −$88,226 | −57.16% |
| 2024 | 2024-12-31 | $154,359 | −$1.8M | −92.08% |
| 2023 | 2023-12-31 | $1.9M | −$2.2M | −52.80% |
| 2022 | 2022-12-31 | $4.1M | $2.8M | +211.67% |
| 2021 | 2021-12-31 | $1.3M | — | — |
Onconetix quarterly r&d spending
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3,440 | −$108,230 | −96.92% |
| Q1 2026 | 2026-03-31 | $50,818 | $26,363 | +107.80% |
| Q4 2025 | 2025-12-31 | $24,293 | — | — |
| Q3 2025 | 2025-09-30 | $3,211 | −$106,154 | −97.06% |
| Q2 2025 | 2025-06-30 | $111,670 | $107,990 | +2934.51% |
| Q1 2025 | 2025-03-31 | $24,455 | −$24,509 | −50.06% |
| Q3 2024 | 2024-09-30 | $109,365 | −$109,873 | −50.12% |
| Q2 2024 | 2024-06-30 | $3,680 | −$843,173 | −99.57% |
| Q1 2024 | 2024-03-31 | $48,964 | −$1.0M | −95.48% |
| Q3 2023 | 2023-09-30 | $219,238 | −$956,242 | −81.35% |
| Q2 2023 | 2023-06-30 | $846,853 | −$446,614 | −34.53% |
| Q1 2023 | 2023-03-31 | $1.1M | $627,145 | +137.81% |
| Q4 2022 | 2022-12-31 | $1.2M | $768,323 | +175.69% |
| Q3 2022 | 2022-09-30 | $1.2M | $905,555 | +335.48% |
| Q2 2022 | 2022-06-30 | $1.3M | $763,925 | +144.26% |
| Q1 2022 | 2022-03-31 | $455,092 | $366,855 | +415.76% |
| Q4 2021 | 2021-12-31 | $437,326 | — | — |
| Q3 2021 | 2021-09-30 | $269,925 | — | — |
| Q2 2021 | 2021-06-30 | $529,542 | — | — |
| Q1 2021 | 2021-03-31 | $88,237 | — | — |
Onconetix r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Onconetix's r&d spending decreased from $1.3M to $66,133, a change of −$1.3M. The latest reported quarter, Q2 2026, shows $3,440.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix source filings ↗